icon
icon
icon
icon
$300 Off
$300 Off

News /

Articles /

Service Corporation International (SCI) Q1 2025 Earnings: Strong Fundamentals Amid Transition Challenges

Rhys NorthwoodThursday, May 1, 2025 3:47 pm ET
61min read

Service Corporation International (SCI), the largest North American deathcare provider, delivered mixed yet encouraging results in its Q1 2025 earnings report. While the stock dipped 4.88% post-earnings due to near-term concerns, the company’s robust cash flow, strategic initiatives, and long-term outlook suggest resilience in an evolving market. Below is an analysis of the key takeaways and investment implications.

Ask Aime: Invest in SCI for long-term growth?

Key Financial Highlights

SCI reported an adjusted EPS of $0.96, a 7.8% year-over-year increase, surpassing analysts’ expectations of $0.93. Revenue rose to $1.07 billion, in line with forecasts. The adjusted operating cash flow surged 43% to $316 million, driven by margin improvements and cost discipline. Management reaffirmed its full-year EPS guidance of $3.70–$4.00, implying a 9% midpoint growth, while maintaining a $830–$890 million operating cash flow target.

Ask Aime: "Has SCI's Q1 2025 earnings report revealed a resilient long-term outlook, despite a 4.88% stock dip post-results?"

SCI Closing Price

Segment Performance: Funeral Strength, Cemetery Challenges

  • Funeral Division:
  • Revenue grew 4% to $534.9 million, fueled by a 2.3% rise in average revenue per service to $5,748 and a 1.8% increase in services performed.
  • Preneed sales, however, fell 10% to $284.1 million due to the transition to insurance-funded contracts, which disrupted SCI Direct operations. Management expects this to stabilize by late 2025, with preneed sales rebounding to low-to-mid-single-digit growth in 2026.

    Ask Aime: What impact will SCI's Q1 2025 earnings have on the deathcare sector?

  • Cemetery Division:

  • Revenue dipped 2% to $399.5 million, primarily from a 6% drop in preneed property sales. Gross profit declined 4%, but management emphasized a focus on long-term property development.

Cash Flow and Capital Allocation

SCI returned $176 million to shareholders in Q1, including $46 million in dividends (a 10% annual increase) and $130 million in share repurchases. With $1.6 billion in liquidity, the company plans $75–125 million in acquisitions for cemetery expansions and funeral home upgrades. The net debt/EBITDA ratio improved to 3.59x, within its 3.5–4.0x target.

Outlook and Risks

  • Growth Drivers:
  • Funeral margins are expected to expand 80–120 basis points as the insurance preneed model boosts high-margin commissions.
  • Cemetery sales could grow 1–2%, supported by property development and strong April sales momentum.

  • Challenges:

  • Flat funeral volumes and a stabilizing cremation rate (up 40 basis points) may limit top-line growth.
  • Economic uncertainty could delay preneed sales, though SCI’s 11-year dividend growth streak and defensive sector positioning offer resilience.
  • Supply chain risks, including tariffs on imported goods, remain manageable with 60% of merchandise sourced domestically.

Investor Sentiment and Stock Reaction

SCI’s stock fell post-earnings due to concerns about preneed transition impacts and flat funeral volumes. However, analysts maintain a “strong buy” consensus, citing a 14% upside potential and SCI’s $1.26 billion trailing EBITDA. The beta of 0.82 underscores its low volatility compared to broader markets.

Conclusion: A Buy Amid Transition

SCI’s Q1 results highlight a company in transition but fundamentally strong. While short-term headwinds from preneed model shifts and flat funeral volumes are valid concerns, the company’s cash flow generation, disciplined capital allocation, and long-term strategies—such as cemetery property development and insurance-driven preneed sales—position it for sustained growth.

With $3.85 in 2025 EPS guidance, a 2.3% dividend yield, and a 10-year average return of 12%, SCI offers a compelling risk-reward profile. Investors should focus on the long-term trajectory: preneed sales are still 27% higher than 2019 levels, and the funeral segment’s margin expansion plans suggest profitability resilience.

While the stock’s dip reflects near-term execution risks, the company’s defensive sector role and solid balance sheet make it a hold-to-buy for investors with a multi-year horizon.

Final Takeaway: SCI’s fundamentals remain intact, and the current dip presents an entry point for those willing to ride out transitional challenges. The path to $4.00 EPS—and beyond—remains achievable with strategic execution.

Comments

Add a public comment...
Post
User avatar and name identifying the post author
CrimsonBrit
05/01
2.3% div yield ain't bad. Holding a small position, reinvesting dividends. Let's see if they hit that $4 EPS.
0
Reply
User avatar and name identifying the post author
johnnyko55555
05/01
$SCI dip a buy opportunity, IMO.
0
Reply
User avatar and name identifying the post author
CommonEar474
05/01
SCI's cash flow is solid, but preneed transition got them shook. Long-term, I'm bullish on funeral margins expanding. 📈
0
Reply
User avatar and name identifying the post author
hhh888hhhh
05/01
@CommonEar474 What do you think about their cemetery growth strategy?
0
Reply
User avatar and name identifying the post author
Booknerdworm
05/01
Cemetery property development could be the play. SCI's not just sitting, they're expanding. Keep an eye on that strategy.
0
Reply
User avatar and name identifying the post author
Zestyclose_Gap_100
05/01
Cemetery growth potential underrated in my opinion.
0
Reply
User avatar and name identifying the post author
Emgimeer
05/01
@Zestyclose_Gap_100 True, cemetery growth might be underestimated.
0
Reply
User avatar and name identifying the post author
iyankov96
05/01
$SCI might dip again, but analysts are holding strong buy. Don't sleep on this potential 14% upside. 🚀
0
Reply
User avatar and name identifying the post author
Ecstatic_Book4786
05/01
Funeral margins up, bullish on $SCI long-term.
0
Reply
User avatar and name identifying the post author
Wanderer_369
05/01
Holding $SCI long-term; trust their strategy, but watching preneed sales closely. Diversification is key.
0
Reply
User avatar and name identifying the post author
btcmoney420
05/01
Holding $SCI, waiting for preneed bounce back.
0
Reply
User avatar and name identifying the post author
fluffnstuff1
05/01
Preneed hiccups, but cash flow solid. 🚀
0
Reply
User avatar and name identifying the post author
Jengabuilding
05/01
Damn!!The SCI stock triggered a trading signal, resulting in substantial gains for me.
0
Reply
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App